课题基金 / 基金详情

Development of DC-based vaccine therapy by utilizing exosomes collected from healthy volunteer-derived DCs

Development of DC-based vaccine therapy by utilizing exosomes collected from healthy volunteer-derived DCs
利用从健康志愿者衍生的 DC 中收集的外泌体开发基于 DC 的疫苗疗法
批准号:
18591440
负责人:
MORISAKI Takashi
金额:
$2.39万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007

项目摘要

项目成果

MORISAKI Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是开发一种制备树突状细胞(DC)的方法,这种树突状细胞具有在个体之间具有相同的抗原递呈能力,作为癌症患者的治疗工具。利用健康志愿者外周血单个核细胞(PBMC)来源的树突状细胞(DC)分泌的外切体作为研究对象是本研究的独特之处。研究期间获得的数据如下:1)DC来源的外切体的定性和定量评价方法:我们发展了一种结合超速离心法、蔗糖密度法和BDLA-DR结合珠的新方法来提纯和定性定量评价外切体。结果表明,在健康志愿者DC来源的外体上,关键抗原提呈相关分子,包括MHC-II类分子、CD80、CD86和ICAM-1均有高度且均一的表达。另一方面,这些分子在患者来源的DC的外切体上的表达很弱。2)DC来源的Exosome对DC分化和功能的影响:2-1:健康志愿者DC来源的Exosome对CD4T细胞存活的延长。2-2:健康志愿者来源的DC的Exosome促进患者来源DC的分化。2-3提高健康志愿者DC来源的Exosome的NK细胞活性。2-4:从肿瘤细胞冲击的DC收集的Exosome诱导细胞毒性T细胞(CTL)。5):从恶性积液中收集的外切体可延长调节性T细胞的存活时间。3)其他:从CE4基因转染树突状细胞分泌的外切体可能表达CEA。
英文摘要
Aim of this study is to develop a method for preparing dendritic cells (DCs), which have homogeneous ability of antigen presentation between individuals, as therapeutic tool for cancer patients. It is a unique point that exosomes secreted by DCs generated from healthy volunteers' peripheral blood mononuclear cells (PBMCs) are utilized for this ourpose.Data obtained during the research period are as follows:1) Methodology for qualitative and quantitative evaluation of DC-derived exosomes:We developed a new methodology for purification and qualitative and quantitative evaluation of exosomes by combination of ultracentrifugation, sucrose density, and BDLA-DR-bound beads. As a result, it was shown tat critical antigen presentation-related molecules, including MHC class II, CD80, CD86, and ICAM-1, are expressed highly and homogeneously on exosomes derived from healthy volunteer's DCs. On the other hand, expressions of these molecules were weak on exosomes derived from patient-derived DCs.In conclusion, it was strongly indicated that expression of HLA-DR on purified exosomes is a marker for qualitative and quantitative evaluation of DC-derived exosomes.2)Effects of DC"derived exosomes on differentiation and function of DCs:2-1: Survival prolongation of CD4+ T cells by exosomes collected from healty volunteer-derived DCs.2-2: Improved differentiation of patient-derived DCs by exosomes collected from healty volunteerderived DCs.2-3 increased NK cell activity by exosomes collected from healty volunteerderived DCs.2-4: Induction of cytotoxic T cells (CTLs) by exosomes collected from tumor cell-pulsed DCs.2-5: Survival prolongation of regulatory T cells by exosomes collectede from malignant effusions.3)Others:An interesting possibility that exosomes secreted from CE4-transfected DCs express CEA was indicated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
担癌間者胸腹水中の制御性T細胞(Treg細胞)増加の機序解析
癌症患者胸腹水中调节性T细胞(Treg细胞)增加的机制分析
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [和田 純治, ほか]
通讯作者: ほか
癌患者末梢血中の制御性T細胞(Treg細胞)増加の機序解析と癌免疫療法におけるTreg細胞測定の臨床的意義
癌症患者外周血调节性T细胞(Treg细胞)增加的机制分析及Treg细胞测量在癌症免疫治疗中的临床意义
DOI: --
发表时间: 2007
期刊:
影响因子: --
作者: [和田 純治, ほか]
通讯作者: ほか
DOI: 10.1007/s00280-006-0219-4
发表时间: 2006-11-01
期刊: CANCER CHEMOTHERAPY AND PHARMACOLOGY
影响因子: 3
作者: [Qin, Baoli, Ariyama, Hiroshi, Nakano, Shuji]
通讯作者: Nakano, Shuji
Regulatory T cells are possible effect prediction markers of immunother apy for cancer patients
调节性T细胞可能是癌症患者免疫治疗效果预测标志物
DOI: --
发表时间:
期刊: Anticancer Research (in press)
影响因子: --
作者: [Wada J, et. al.]
通讯作者: et. al.
Development of new therapeutical strategy for lung NET by inhibiting Hh/Notch signaling targeting RBPJ
  • 批准号:
    18K08788
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.83万
  • 财政年份:
    2018
  • 负责人:
    MORISAKI Takashi
  • 依托单位:
The development of the system estimating realtime antitumor activity of activated T lymphocytes in cancer immunotherapy
  • 批准号:
    24591908
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.41万
  • 财政年份:
    2012
  • 负责人:
    MORISAKI Takashi
  • 依托单位:
Suppression of induction and accumulation at tumor site of regulatory T cells by inhibition of VEGF/VEGFR2 pathway
  • 批准号:
    21591670
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2009
  • 负责人:
    MORISAKI Takashi
  • 依托单位:
Arificial biliary duct model for surgical therapeutic material and research material for biliary cancer
  • 批准号:
    13671245
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.62万
  • 财政年份:
    2001
  • 负责人:
    MORISAKI Takashi
  • 依托单位:
国内基金
海外基金
TMUV-Exosomes调控宿主PKR蛋白磷酸化促进TMUV复制的分子机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2024
  • 负责人:
    梅堃
  • 依托单位:
乳腺癌细胞 Exosomes-miR-137 靶向降解巨噬 细胞 DUSP4 从而促进免疫抑制微环境形成的 作用研究
  • 批准号:
    TGY24H160033
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    王淑倩
  • 依托单位:
尿液Exosomes中lncRNA表达谱分析在肾结石肾纤维化早期诊断中的应用价值研究
  • 批准号:
    82360157
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    32万元
  • 批准年份:
    2023
  • 负责人:
    陈大进
  • 依托单位:
过表达COL7A1的USCs-exosomes@MOFs复合SIS水凝胶治疗隐性营养不良型大疱性表皮松解症的作用研究
  • 批准号:
    82304062
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    周兴丽
  • 依托单位: